Your browser doesn't support javascript.
loading
Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.
Yaghy, Antonio; Lee, Aaron Y; Keane, Pearse A; Keenan, Tiarnan D L; Mendonca, Luisa S M; Lee, Cecilia S; Cairns, Anne Marie; Carroll, Joseph; Chen, Hao; Clark, Julie; Cukras, Catherine A; de Sisternes, Luis; Domalpally, Amitha; Durbin, Mary K; Goetz, Kerry E; Grassmann, Felix; Haines, Jonathan L; Honda, Naoto; Hu, Zhihong Jewel; Mody, Christopher; Orozco, Luz D; Owsley, Cynthia; Poor, Stephen; Reisman, Charles; Ribeiro, Ramiro; Sadda, Srinivas R; Sivaprasad, Sobha; Staurenghi, Giovanni; Ting, Daniel Sw; Tumminia, Santa J; Zalunardo, Luca; Waheed, Nadia K.
Afiliação
  • Yaghy A; New England Eye Center, Tufts University Medical Center, Boston, MA, USA.
  • Lee AY; Department of Ophthalmology, University of Washington, Seattle, WA, USA; Karalis Johnson Retina Center, Seattle, WA, USA.
  • Keane PA; Moorfields Eye Hospital & UCL Institute of Ophthalmology, London, UK.
  • Keenan TDL; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
  • Mendonca LSM; Federal University of Sao Paulo, Sao Paulo, Brazil.
  • Lee CS; Department of Ophthalmology, University of Washington, Seattle, WA, USA; Karalis Johnson Retina Center, Seattle, WA, USA.
  • Cairns AM; Optos Plc, Dunfermline, Scotland, United Kingdom.
  • Carroll J; Department of Ophthalmology & Visual Sciences, Medical College of Wisconsin, 925 N 87th Street, Milwaukee, WI, 53226, USA.
  • Chen H; Genentech, South San Francisco, CA, USA.
  • Clark J; Iveric Bio, Parsippany, NJ, USA.
  • Cukras CA; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
  • de Sisternes L; Carl Zeiss Meditec, Inc, Dublin, CA, USA.
  • Domalpally A; Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA.
  • Durbin MK; Carl Zeiss Meditec, Inc, Dublin, CA, USA.
  • Goetz KE; Office of the Director, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
  • Grassmann F; Health and Medical University, Potsdam, Germany.
  • Haines JL; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Cleveland Institute of Computational Biology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Honda N; Nidek, CO. LTD, Aichi, Japan.
  • Hu ZJ; Doheny Eye Institute, University of California, Los Angeles, CA, USA.
  • Mody C; Heidelberg Engineering, Heidelberg, Germany.
  • Orozco LD; Department of Bioinformatics, Genentech, South San Francisco, CA, 94080, USA.
  • Owsley C; Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Poor S; Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Reisman C; Heidelberg Engineering, Heidelberg, Germany.
  • Ribeiro R; Apellis Pharmaceuticals, Waltham, MA, USA.
  • Sadda SR; Doheny Eye Institute, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA.
  • Sivaprasad S; NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
  • Staurenghi G; Department of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan, Italy.
  • Ting DS; Singapore Eye Research Institute, Singapore National Eye Center, Duke-NUS Medical School, National University of Singapore, Singapore.
  • Tumminia SJ; Office of the Director, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
  • Zalunardo L; Icare USA Inc, Raleigh, NC, USA.
  • Waheed NK; New England Eye Center, Tufts University Medical Center, Boston, MA, USA. Electronic address: nadiakwaheed@gmail.com.
Exp Eye Res ; 220: 109092, 2022 07.
Article em En | MEDLINE | ID: mdl-35525297

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inteligência Artificial / Degeneração Macular Limite: Humans Idioma: En Revista: Exp Eye Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inteligência Artificial / Degeneração Macular Limite: Humans Idioma: En Revista: Exp Eye Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos